Intersect ENT
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Option
WOLBECK AMY officer: V.P. Regulatory Affair..
Stock Option (right to buy) 2,000 N/A N/A
Sale
KAUFMAN RICHARD E officer: Technical Advisor
Common Stock 3,603 N/A N/A
Option
EARNHARDT LISA D director
Stock Option (right to buy) 4,000 N/A N/A
Sale
EARNHARDT LISA D director
Common Stock 8,500 N/A N/A
Option
EARNHARDT LISA D director
Common Stock 4,000 N/A N/A
Option
EARNHARDT LISA D director
Stock Option (right to buy) 20,000 N/A N/A
Option
EARNHARDT LISA D director
Common Stock 20,000 N/A N/A
Sale
EARNHARDT LISA D director
Common Stock 20,000 N/A N/A
Sale
KAUFMAN RICHARD E officer: Technical Advisor
Common Stock 3,603 N/A N/A
Sale
EARNHARDT LISA D director
Common Stock 9,000 N/A N/A
Sale
MOLL FREDERIC H director
Common Stock 1,299 N/A N/A
Sale
MOLL FREDERIC H director
Common Stock 601 N/A N/A
Sale
MOLL FREDERIC H director
Common Stock 12,500 N/A N/A
Option
MOLL FREDERIC H director
Stock Option (right to buy) 12,500 N/A N/A
Option
MOLL FREDERIC H director
Common Stock 12,500 N/A N/A
Sale
KAUFMAN RICHARD E officer: Technical Advisor
Common Stock 3,603 N/A N/A
Sale
KAUFMAN RICHARD E officer: Technical Advisor
Common Stock 3,603 N/A N/A
Sale
KAUFMAN RICHARD E officer: Technical Advisor
Common Stock 3,603 N/A N/A
Option
EARNHARDT LISA D director
Common Stock 8,000 N/A N/A
Option
EARNHARDT LISA D director
Stock Option (right to buy) 8,000 N/A N/A
Sale
EARNHARDT LISA D director
Common Stock 12,500 N/A N/A
Option
WOLBECK AMY officer: V.P. Regulatory Affair..
Common Stock 5,700 N/A N/A
Option
WOLBECK AMY officer: V.P. Regulatory Affair..
Stock Option (right to buy) 5,700 N/A N/A
Sale
EARNHARDT LISA D director
Common Stock 6,820 N/A N/A
Sale
EARNHARDT LISA D director
Common Stock 6,818 N/A N/A
Option
STAMBAUGH JAMES officer: VP Clinical Affairs
Common Stock 20,000 N/A N/A
Option
STAMBAUGH JAMES officer: VP Clinical Affairs
Stock Option (right to buy) 20,000 N/A N/A
Sale
EARNHARDT LISA D director
Common Stock 6,818 N/A N/A
Sale
EARNHARDT LISA D director
Common Stock 6,818 N/A N/A
Sale
MOLL FREDERIC H director
Common Stock 10,000 N/A N/A
Option
STAMBAUGH JAMES officer: VP Clinical Affairs
Stock Option (right to buy) 4,000 N/A N/A
Option
STAMBAUGH JAMES officer: VP Clinical Affairs
Common Stock 4,000 N/A N/A
Sale
EARNHARDT LISA D director
Common Stock 6,818 N/A N/A
Option
STAMBAUGH JAMES officer: VP Clinical Affairs
Stock Option (right to buy) 12,000 N/A N/A
Option
STAMBAUGH JAMES officer: VP Clinical Affairs
Common Stock 12,000 N/A N/A
Sale
STAMBAUGH JAMES officer: VP Clinical Affairs
Common Stock 12,000 N/A N/A
Sale
EARNHARDT LISA D director
Common Stock 19,318 N/A N/A
Sale
EARNHARDT LISA D director
Common Stock 19,318 N/A N/A
Sale
KAUFMAN RICHARD E officer: Technical Advisor
Common Stock 8,000 N/A N/A
Sale
EARNHARDT LISA D director
Common Stock 19,318 N/A N/A
Option
WOLBECK AMY officer: V.P. Regulatory Affair..
Stock Option (right to buy) 80 N/A N/A
Sale
WOLBECK AMY officer: V.P. Regulatory Affair..
Common Stock 80 N/A N/A
Option
WOLBECK AMY officer: V.P. Regulatory Affair..
Common Stock 80 N/A N/A
Sale
STAMBAUGH JAMES officer: VP Clinical Affairs
Common Stock 2,785 N/A N/A
Sale
EARNHARDT LISA D director
Common Stock 19,318 N/A N/A
Sale
WOLBECK AMY officer: V.P. Regulatory Affair..
Common Stock 16,000 N/A N/A
Option
WOLBECK AMY officer: V.P. Regulatory Affair..
Common Stock 16,000 N/A N/A
Option
WOLBECK AMY officer: V.P. Regulatory Affair..
Stock Option (right to buy) 8,500 N/A N/A
Sale
STAMBAUGH JAMES officer: VP Clinical Affairs
Common Stock 8,343 N/A N/A
Sale
EARNHARDT LISA D director
Common Stock 19,318 N/A N/A

Showing 200 to 250 of 266 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.